Abstract
Abstract: A clear understanding of normal physiological distribution of the radiopharmaceutical, commonly encountered normal variants, and benign pathologic uptake is important to avoid mistaken diagnosis on an F-18 FDG PET scan. The distribution of FDG in the bowel is variable and may occasionally lead to diagnostic pitfalls. Chilaiditi sign is a well-known anatomic variant and describes the interposition of bowel between the liver and diaphragm. The authors present a case where an apparent abnormality in the liver on an FDG PET only study was proven to be due to bowel activity related to Chilaiditi sign on CT correlation.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have